L&C Bio Co. Ltd (KQ:290650) — Stock Price
L&C Bio Co. Ltd (KQ:290650) is currently trading at ₩64600.00 KRW, up 4.19% today. Over the past 52 weeks, shares have ranged between ₩29400.00 and ₩118300.00. This page tracks L&C Bio Co. Ltd's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see L&C Bio Co. Ltd (290650) total market value.
L&C Bio Co. Ltd (290650) Stock Price Chart — Daily History & Trading Volume
The chart below tracks L&C Bio Co. Ltd's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
L&C Bio Co. Ltd Income Statement — Revenue, Profit & Earnings by Year
L&C Bio Co. Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | ₩72.09 Billion | ₩65.93 Billion | ₩52.57 Billion | ₩45.68 Billion | ₩32.97 Billion |
| Cost of Revenue | ₩36.36 Billion | ₩32.07 Billion | ₩25.58 Billion | ₩17.23 Billion | ₩13.41 Billion |
| Gross Profit | ₩35.73 Billion | ₩33.86 Billion | ₩26.99 Billion | ₩28.45 Billion | ₩19.56 Billion |
| Research & Development | ₩4.91 Billion | ₩3.15 Billion | ₩2.20 Billion | ₩2.29 Billion | ₩2.38 Billion |
| SG&A | ₩25.86 Billion | ₩20.48 Billion | ₩13.94 Billion | ₩12.06 Billion | ₩9.55 Billion |
| Total Operating Expenses | ₩69.55 Billion | ₩57.80 Billion | ₩43.09 Billion | ₩32.51 Billion | ₩25.65 Billion |
| Operating Income | ₩2.52 Billion | ₩5.75 Billion | ₩9.52 Billion | ₩13.17 Billion | ₩7.32 Billion |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | ₩9.48 Billion | ₩13.17 Billion | ₩7.32 Billion |
| Interest Expense | ₩3.22 Billion | ₩6.17 Billion | ₩3.08 Billion | ₩460.27 Million | ₩743.24 Million |
| Income Before Tax | ₩137.79 Billion | ₩63.27 Billion | ₩4.56 Billion | ₩17.10 Billion | ₩12.94 Billion |
| Income Tax Expense | — | — | ₩-1.13 Billion | ₩1.51 Billion | ₩795.51 Million |
| Net Income | ₩141.06 Billion | ₩48.36 Billion | ₩4.54 Billion | ₩13.81 Billion | ₩10.81 Billion |
L&C Bio Co. Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes L&C Bio Co. Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | ₩475.60 Billion | ₩262.23 Billion | ₩199.73 Billion | ₩107.40 Billion | ₩80.58 Billion |
| Total Current Assets | ₩130.19 Billion | ₩130.36 Billion | ₩64.28 Billion | ₩47.63 Billion | ₩45.50 Billion |
| Cash & Equivalents | ₩18.29 Billion | ₩14.95 Billion | ₩6.59 Billion | ₩9.47 Billion | ₩4.64 Billion |
| Short-term Investments | ₩5.85 Billion | ₩44.24 Billion | ₩5.73 Billion | ₩10.15 Billion | ₩22.71 Billion |
| Net Receivables | ₩21.73 Billion | ₩18.22 Billion | ₩13.19 Billion | ₩12.72 Billion | ₩9.10 Billion |
| Inventory | ₩46.78 Billion | ₩46.29 Billion | ₩34.20 Billion | ₩12.31 Billion | ₩8.08 Billion |
| Property, Plant & Equipment | ₩97.02 Billion | ₩74.66 Billion | ₩53.14 Billion | ₩17.90 Billion | ₩9.48 Billion |
| Goodwill | ₩197.31 Billion | ₩0.00 | ₩2.32 Billion | — | — |
| Total Liabilities | ₩191.25 Billion | ₩115.29 Billion | ₩101.77 Billion | ₩22.38 Billion | ₩22.77 Billion |
| Total Current Liabilities | ₩154.71 Billion | ₩101.84 Billion | ₩18.74 Billion | ₩5.63 Billion | ₩3.67 Billion |
| Long-term Debt | ₩20.06 Billion | ₩541.32 Million | ₩70.57 Billion | ₩5.45 Billion | ₩13.94 Billion |
| Net Debt | ₩100.38 Billion | ₩64.91 Billion | ₩73.65 Billion | — | — |
| Total Stockholder Equity | ₩284.35 Billion | ₩146.94 Billion | ₩97.95 Billion | ₩85.02 Billion | ₩57.81 Billion |
| Retained Earnings | ₩222.20 Billion | ₩83.59 Billion | ₩36.87 Billion | ₩33.34 Billion | ₩20.64 Billion |
L&C Bio Co. Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how L&C Bio Co. Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₩-8.57 Billion | ₩-12.13 Billion | ₩-6.08 Billion | ₩10.91 Billion | ₩7.42 Billion |
| Capital Expenditures | ₩5.35 Billion | ₩24.98 Billion | ₩37.53 Billion | ₩10.25 Billion | ₩3.02 Billion |
| Free Cash Flow | ₩-13.92 Billion | ₩-37.12 Billion | ₩-43.78 Billion | ₩-521.15 Million | ₩4.36 Billion |
| Investing Cash Flow | ₩-21.95 Billion | ₩24.63 Billion | ₩-83.63 Billion | ₩-20.49 Billion | ₩823.50 Million |
| Financing Cash Flow | ₩33.83 Billion | ₩-4.16 Billion | ₩78.93 Billion | ₩4.70 Billion | ₩1.26 Billion |
| Dividends Paid | ₩2.27 Billion | ₩1.11 Billion | ₩1.11 Billion | ₩1.08 Billion | ₩729.33 Million |
| Stock-Based Compensation | ₩149.56 Million | ₩138.88 Million | ₩375.83 Million | ₩727.41 Million | ₩290.47 Million |
| Depreciation | ₩6.22 Billion | ₩5.24 Billion | ₩4.51 Billion | ₩2.90 Billion | ₩1.59 Billion |
| Change in Cash | ₩3.34 Billion | ₩8.36 Billion | ₩-10.79 Billion | ₩-4.88 Billion | ₩9.50 Billion |
L&C Bio Co. Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track L&C Bio Co. Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | -2288.69 | — | — |
| Jun 30, 2025 | -580.49 | — | — |
| Mar 31, 2025 | -18.85 | — | — |
| Dec 31, 2024 | 6402.77 | — | — |
| Sep 30, 2024 | -227.97 | — | — |
| Jun 30, 2024 | 46.95 | — | — |
| Mar 31, 2024 | 68.41 | — | — |
| Dec 31, 2023 | -150.16 | — | — |